Navigation Links
Us TOO Launches National 'SEA Blue' Campaign for Prostate Cancer Awareness Month
Date:8/30/2007

or prostate cancer awareness and action as wearing denim for a day has done for breast cancer awareness and action. Every dollar raised will be used for prostate cancer awareness, education, patient advocacy and support, and research programs that might otherwise go unfunded. Planning is underway for the 2008 event, to be held on Friday, June 13.

About Us TOO International

The Us TOO International Prostate Cancer Education & Support Network is the first and largest nationwide prostate awareness, education and support organization (http://www.ustoo.org), with more than 300 local chapters and 52,000 members. Founded in 1990 by five men who had been treated for prostate cancer, the organization derived its name from the notion that "Us TOO" might work for prostate cancer as well as the "Y-Me" name did for breast cancer.

A registered 501(c) (3) nonprofit organization, Us TOO International holds the highest 4-Star fiscal management rating from Charity Navigator.

Media Contacts

For more information about Us TOO, "SEA Blue" prostate cancer awareness campaign and "Sneakers at Work Day," contact: Pam Barrett at (630) 795-1002, pam@ustoo.org, or George Ledwith at (914) 588-9446, george.ledwith@gmail.com.


'/>"/>
SOURCE Us TOO International
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Pfizer Launches Viagra For Lung Disease In UK
8. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...A, S.C., Nov. 21 U.S. N...for Quality Assurance (NCQA) ranked BlueChoice(R) ...merica,s Best Health Plans(TM), published in U.S. ..., The respected annual ranking ranks the nation,...ber satisfaction and NCQA accreditation scores. NC...
(Date:11/21/2008)...N LAKES, N.J., Nov. 21 T...medical intervention in treating 88 percent of pat...t of Americans treated for a chronic condition acc...ing and 75 percent of all medical costs. A propri...s by Medco Health Solutions, Inc. (NYSE: MHS ) s...
(Date:11/21/2008)...ound 2 popular drugs do not cause genetic damage t... 21 (HealthDay News) -- Two popular medications fo...r (ADHD) do not cause genetic damage linked to an ...says. , The study, done by researchers at Duke ...tes of Health, counters a previous one that report...
(Date:11/21/2008)...0 B.C., a new and deadly diseaseits cause remains ...state was teeming with citizens, soldiers and refu...rta. As streets filled with corpses, social order ... returned twice and Athens lost a third of its pop... marked the beginning of the end of the Golden Age...
Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...s have measurable anomalies in their immune system...idely believed that stress may impair health, alth...w researchers at Washington University in the US r... has a specific effect on immunity. When an infla...
... and infallible test for bowel cancer based upon a...now that bowel cancer is highly curable if caught ...exam// of the bowel can reduce the incidence of th... that a reliable test can also be done on samples ...
...ical and Research Center report in the New England...matitis, also known as eczema, are susceptible to ...fail to produce effective amounts of two antimicro...cal significance of these peptides in humans, and ...
...t was observed that the valve helps patients with ...tions. The main symptom of esophagal cancer is dif...s often well advanced by the time this symptom// b... generally poor and quite often all that can be do...
Other Medicine News:Health News:Eczema patients lack natural antibiotic in skin 2
(Date:11/20/2008)...e/ -- New Jersey American Water has lifted the pr... in the following municipalities in Middlesex, Som...nty , , , Dunellen , Edison ...uth Plainfield , , , , Somerset Cou...gewater , Green Brook , Hillsborough...
(Date:11/20/2008)...re-FirstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI ) ...e Phase 1B,clinical trial of their lead drug cand...01, at the Society for Integrative Oncology,s Fift...The Company,s oral presentation was selected,as a...art of the Best of the,SIO Session on November 20...
(Date:11/20/2008)...wswire/ -- The Scandinavian-based drug,developmen... studies on its,lead antimicrobial candidate LTX-...udies showed that the novel lytic peptidomimetic h...ntly better towards killing Staphylococcus,aureus...ndard drugs. In,addition to this it has proven ef...
(Date:11/19/2008)...re/ -- Biotech scientists increasingly are applyin...better understand the effects of novel drug candid...ic Engineering & Biotechnology News ( GEN ). ...ew compound,s mechanism of action and eventually d...ding to the November 15 issue of GEN . ( http://w...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Viral recombination another way HIV fools the immune system 4135 1Viral recombination another way HIV fools the immune system 4135 2Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 24245 1Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 24245 2Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 24245 3A virtual toothache helps student dentists 24244 1A virtual toothache helps student dentists 24244 2A virtual toothache helps student dentists 24244 3Lung Cancer Trial Targets Asbestos Related Disease 24241 1Lung Cancer Trial Targets Asbestos Related Disease 24241 2
.... , AURORA, ON, March 30, 2007 /PRNewswire-FirstCa...its phase II clinical study of its,Topical Interfe...HPV) induced low-grade cervical lesions. , The stu...atment,in nearly half of the treated patients. In ...fety profile, with no significant local,intoleranc...
... of Working Age People with Diabetes, Hospital,and...nal Averages, PITTSBURGH, April 02, 2007 /PRNewswi...Health (PBGH) announced today the,release of a new...re for people with Type 2 diabetes. The inaugural ...s an overview of patient,demographics, hospital an...
Other Medicine Technology:Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 2Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 3Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 4Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 5Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 6State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4
The Chalam Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens. This lens was developed with K.V. Chalam,
...enses offer the high resolution, high magnificatio... simple two part design separates for easy cleanin... Simply autoclave, add saline or water to the cont...oClave Sterilizable Lenses The ACS Vitrectomy Lens...
With somewhat higher magnification and increased stereopsis, the Central Retinal is best suited for detailed visualization to the equatorial regions. The Central Retinal is ideal for vitrectomy in di
MiniQuad XL is recommended for evaluating vitreoretinal relationships of the entire fundus and in the management of dislocated lenses. It is the ideal lens for small pupil fundus viewing with the ope
Medicine Products: